Uveitis
📧 Sign up to get email alerts when something new happens for Uveitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-10-01Clinical Trial Update: Open Label Study of Acthar SQ Gel Injection in Patients With Active Anterior Uveitis [Phase 4]
A Phase 4 open-label study of Acthar SQ Gel Injection in patients with active anterior uveitis was terminated with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-08-20Clinical Trial Update: Sirolimus as Therapeutic Approach to Uveitis [Phase 1]
Phase 1 clinical trial evaluating sirolimus as a therapeutic approach for uveitis has completed, with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients [Phase 4]
A Phase 4 clinical trial evaluating Acthar Gel for uveitis has completed and posted results in July 2018.
-
CLINICAL_TRIALS trial_result · 2018-05-16Clinical Trial Update: RNFL Thickness Measurements Obtained Using SD-OCT and SLP Using GDx Variable Corneal Compensation
A completed trial evaluated retinal nerve fiber layer thickness in uveitis patients using spectral-domain optical coherence tomography and s…
-
CLINICAL_TRIALS trial_result · 2017-10-26Clinical Trial Update: Use of Simvastatin as a Steroid Sparing Agent for Uveitis Patients [Phase 2, Phase 3]
This document provides an update on a Phase 2/3 clinical trial evaluating simvastatin as a steroid-sparing treatment for uveitis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS other · 2017-08-16Clinical Trial Update: Treatment of the Bilateral Severe Uveitis by IVT of Regulator T-cells: Study of Tolerance of Dose [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating intravenous regulatory T-cell therapy for bilateral severe uveitis; the study is currently suspended.
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study
A completed SITE cohort study assessing the safety and outcomes of systemic immunosuppressive therapy for eye diseases, including infections…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Differences in Genes and Proteins in Active and Controlled Uveitis
Clinical trial update examining differences in genes and proteins between active and controlled uveitis.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: ANTI-TAC THERAPY FOR UVEITIS [Phase 1]
A Phase 1 trial evaluating Anti-Tac Therapy for uveitis has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Daclizumab and Sirolimus to Treat Uveitis [Phase 1]
A Phase 1 trial evaluating the combination of daclizumab and sirolimus for uveitis has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: The Treatment of Uveitic Cystoid Macular Edema With Topical Interferon Gamma [Phase 1]
A Phase 1 trial assessing safety/tolerability of topical interferon gamma for uveitic cystoid macular edema has been completed.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Immune Indicators of Uveitis
A completed study evaluating immune indicators involving GITR and GITR ligand in uveitis to understand immunosuppression mechanisms.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Screening for NEI Clinical Studies
NEI-sponsored clinical trial screening has completed screening for multiple ocular studies, covering conjunctivitis, iritis, keratitis, reti…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Daclizumab to Treat Non-Infectious Sight-Threatening Uveitis [Phase 2]
A Phase 2 clinical trial evaluating daclizumab for non-infectious sight-threatening uveitis has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Eye and Immunogenetic Features of Sarcoidosis
This clinical trial update summarizes findings from a completed study on eye involvement and immunogenetic features in sarcoidosis, includin…
-
CLINICAL_TRIALS withdrawal · 2017-04-25Clinical Trial Update: Autofluorescence in Uveitic and Diabetic Macular Edema
A clinical trial assessing autofluorescence in uveitic and diabetic macular edema has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-04-20Clinical Trial Update: Study of FTY720 in Patients With Uveitis [Phase 2]
A Phase 2 study of FTY720 (fingolimod) in acute noninfectious uveitis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Intravitreal Celecoxib for Chronic Uveitis [Phase 1]
Phase 1 trial evaluating intravitreal celecoxib for chronic uveitis has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-11-29Clinical Trial Update: Study to Treat Uveitis Associated Macular Edema [Phase 2]
A Phase 2 trial for treating uveitis-associated cystoid macular edema was terminated, according to the update.
-
CLINICAL_TRIALS trial_result · 2016-10-17Clinical Trial Update: Conbercept in Choroidal Neovascularization Secondary to Uveitis [Phase 2]
Phase 2 clinical trial evaluating conbercept for choroidal neovascularization secondary to uveitis; current status is not disclosed.
-
EMA withdrawal · 2016-09-30EMA Application withdrawn: Opsiria (sirolimus) — Santen Oy
The EMA withdrew the application for Opsiria (sirolimus) by Santen Oy for uveitis.
-
CLINICAL_TRIALS trial_result · 2016-08-22Clinical Trial Update: Efficacy and Safety of Adalimumab in Patients With Active Uveitis [Phase 3]
Phase 3 trial update on adalimumab for active uveitis showing efficacy and safety results.
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment [Phase 3]
A Phase 3 clinical trial evaluating gevokizumab for non-infectious uveitis has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-06-21Clinical Trial Update: Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis [Phase 3]
Phase 3 trial update on adalimumab for inactive uveitis reports efficacy and safety results.
-
CLINICAL_TRIALS trial_result · 2016-04-08Clinical Trial Update: Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis [Phase 3]
Phase 3 trial of gevokizumab for active non-infectious uveitis was terminated, indicating the study did not proceed to completion as planned…